These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32703301)

  • 1. Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study.
    Hu X; Yang X; Li X; Luo D; Zhou Y; Dong H
    Lipids Health Dis; 2020 Jul; 19(1):173. PubMed ID: 32703301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients.
    Catena C; Colussi G; Nait F; Capobianco F; Sechi LA
    Kidney Blood Press Res; 2015; 40(2):166-75. PubMed ID: 25871336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.
    Li C; Chen Q; Zhang M; Liu Y; Chu Y; Meng F; Wang J; Tang J; Luo J; Niu X; Wei M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):41. PubMed ID: 33468066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of atherosclerotic renal artery stenosis in 1,200 chinese patients undergoing coronary angiography.
    Zhang Y; Ge JB; Qian JY; Ye ZB
    Nephron Clin Pract; 2006; 104(4):c185-92. PubMed ID: 17003570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
    Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
    Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
    Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profiles in patients with atherosclerotic renal artery stenosis.
    Scoble JE; de Takats D; Ostermann ME; Connolly JO; Scott NR; Beeso JA; Poyser KH; Peters TJ; Sherwood RA
    Nephron; 1999; 83(2):117-21. PubMed ID: 10516489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptides in atherosclerotic renal artery stenosis and effects of renal angioplasty.
    Nowakowska-Fortuna E; Saeed A; Guron G; Fu M; Hammarsten O; Jensen G; Herlitz H
    Kidney Blood Press Res; 2013; 37(6):657-66. PubMed ID: 24356556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
    Lin LH; Liu H; Tu Y; Yang Y; Wang B; Wang FM; Wu M; Pan MM; Tang RN; Ma KL; Zhang XL; Liu BC
    Coron Artery Dis; 2019 Mar; 30(2):137-142. PubMed ID: 30585793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).
    Afshar M; Pilote L; Dufresne L; Engert JC; Thanassoulis G
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and risk factors of atherosclerotic renal artery stenosis].
    Yan JH; Sun LX; Zhao XY; Lian H; Ruan YP; Zhu YL; Zhang SY; Fang Q; Fan ZJ
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):827-31. PubMed ID: 23859388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA PR11-387H17.6 as a potential novel diagnostic biomarker of atherosclerotic renal artery stenosis.
    Fu W; Tian X; Liu L; Zhang X; Wang X
    Ren Fail; 2021 Dec; 43(1):1188-1197. PubMed ID: 34369281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid intraplaque neovascularization predicts atherosclerotic renal artery stenosis in patients with carotid artery stenosis.
    Song Y; Dang Y; Cai H; Wang J; Liu B; Feng J; Ruan L
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1492-1499. PubMed ID: 32620336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with atherosclerotic renal artery disease.
    Safak E; Wilke C; Derer W; Busjahn A; Gross M; Moeckel M; Mueller DN; Luft FC; Dechend R
    J Am Soc Hypertens; 2013; 7(1):24-31. PubMed ID: 23321402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of renal artery stenosis in patients undergoing peripheral and coronary angiography.
    Shukla AN; Madan TH; Jayaram AA; Kute VB; Rawal JR; Manjunath AP; Udhreja S
    Int Urol Nephrol; 2013 Dec; 45(6):1629-35. PubMed ID: 23589188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for significant atherosclerotic renal artery stenosis with a regression model in patients undergoing transradial coronary angiography/intervention.
    Pu LJ; Shen Y; Zhang RY; Zhang Q; Lu L; Ding FH; Hu J; Yang ZK; Shen WF
    J Zhejiang Univ Sci B; 2012 Aug; 13(8):631-7. PubMed ID: 22843183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Hohenstein B; Roeseler E; Heigl F; Grützmacher P; Blume H; Klingel R; Vogt A;
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):33-38. PubMed ID: 30838552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.
    Zhao Y; Delaney JA; Quek RG; Gardin JM; Hirsch CH; Gandra SR; Wong ND
    Clin Cardiol; 2016 Jul; 39(7):413-20. PubMed ID: 27177347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.